By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today said revenues for the third quarter jumped 17 percent year over year as the division containing its life science instruments spiked 15 percent.

For the quarter ended Sept. 30, the company posted $310.2 million in revenues, up from $265.1 million a year ago, and surpassing analyst estimates of $293.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.